The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
The clinical value of [90Y-DOTA]-D-Phe1-Tyr3-octreotide (90Y-DOTATOC) in the treatment of neuroendocrine tumours: A clinical phase II study
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer—Principles & Practice of Oncology
Rhoads, J. E. (1983) · PubMed Central · Cited by 1,466
Treatment of the Malignant Carcinoid Syndrome
Kvols, L. K., Moertel, C. G., O'Connell, M. J., Schutt, A. J., Rubin, J., & Hahn, R. G. (1986) · New England Journal of Medicine · doi:10.1056/nejm198609113151102 · Cited by 849
LOCALISATION OF ENDOCRINE-RELATED TUMOURS WITH RADIOIODINATED ANALOGUE OF SOMATOSTATIN
Krenning, E. P., Breeman, W. A. P., Kooij, P. P. M., Lameris, J. S., Bakker, W. H., Koper, J. W., Ausema, L., Reubi, J. C., & Lamberts, S. W. J. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91258-0 · Cited by 625
Somatostatin-Receptor Imaging in the Localization of Endocrine Tumors
Lamberts, S. W. J., Barker, W. H., Reubi, J.-C., & Krenning, E. P. (1990) · New England Journal of Medicine · doi:10.1056/nejm199011013231805 · Cited by 532
Treatment of poorly differentiated neuroendocrine tumours with etoposide and cisplatin
Mitry, E., Baudin, E., Ducreux, M., Sabourin, J.-C., Rufié, P., Aparicio, T., Lasser, P., Elias, D., Duvillard, P., Schlumberger, M., et al. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690325 · Cited by 496
Yttrium-90 DOTATOC: first clinical results
Otte, A., Herrmann, R., Heppeler, A., Behe, M., Jermann, E., Powell, P., Maecke, H. R., & Muller, J. (1999) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s002590050476 · Cited by 420
Self-citationHeppeler, A., Froidevaux, S., Mäcke, H. R., Jermann, E., Béhé, M., Powell, P., & Hennig, M. (1999) · Chemistry - A European Journal · doi:10.1002/(sici)1521-3765(19990702)5:7<1974::aid-chem1974>3.0.co;2-x · Cited by 337
DOTATOC: A powerful new tool for receptor-mediated radionuclide therapy
Otte, A., Jermann, E., Behe, M., Goetze, M., Bucher, H. C., Roser, H. W., Heppeler, A., Mueller-Brand, J., & Maecke, H. R. (1997) · European Journal of Nuclear Medicine · doi:10.1007/bf00879669 · Cited by 224
Self-citationde Jong, M., Bakker, W. H., Krenning, E. P., Breeman, W. A. P., van der Pluijm, M. E., Bernard, B. F., Visser, T. J., Jermann, E., Béhé, M., Powell, P., et al. (1997) · European Journal of Nuclear Medicine · doi:10.1007/bf00881807 · Cited by 215
Ruszniewski, P., Ducreux, M., Chayvialle, J. A., Blumberg, J., Cloarec, D., Michel, H., Raymond, J. M., Dupas, J. L., Gouerou, H., Jian, R., et al. (1996) · Gut · doi:10.1136/gut.39.2.279 · Cited by 206
Frank, M. (1999) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(99)00146-x · Cited by 191
Carcinoid tumors and the carcinoid syndrome
Feldman, J. M. (1989) · Current Problems in Surgery · doi:10.1016/0011-3840(89)90010-5 · Cited by 189
Cremonesi, M., Ferrari, M. E., Zoboli, S., Chinol, M., Stabin, M. G., Orsi, F., Maëcke, H. R., Jermann, E., Robertson, C., Fiorenza, M., et al. (1999) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s002590050462 · Cited by 148
The glucagonoma syndrome: Surgically curable diabetes
Higgins, G. A., Recant, L., & Fischman, A. B. (1979) · The American Journal of Surgery · doi:10.1016/0002-9610(79)90025-4 · Cited by 103
Advances in chemotherapy and biotherapy of endocrine tumors
Öberg, K. (1998) · Current Opinion in Oncology · doi:10.1097/00001622-199801000-00010 · Cited by 59
Drug Therapy in Metastatic Neuroendocrine Tumors of the Gastroenteropancreatic System
Faiss, S., Scherübl, H., Riecken, E. O., & Wiedenmann, B. (1996) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-642-80035-1_12 · Cited by 51
Clinical aspects of glucagon-producing islet cell tumors.
Prinz, R. A., Dorsch, T. R., & Lawrence, A. M. (1981) · PubMed · Cited by 51
Cited by
Gastroenteropancreatic neuroendocrine tumours
Modlin, I. M., Oberg, K., Chung, D. C., Jensen, R. T., de Herder, W. W., Thakker, R. V., Caplin, M., Delle Fave, G., Kaltsas, G. A., Krenning, E. P., et al. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(07)70410-2 · Cited by 1,748
Kwekkeboom, D. J., de Herder, W. W., Kam, B. L., van Eijck, C. H., van Essen, M., Kooij, P. P., Feelders, R. A., van Aken, M. O., & Krenning, E. P. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.2553 · Cited by 1,456
Peptide Receptors as Molecular Targets for Cancer Diagnosis and Therapy
Reubi, J. C. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0007 · Cited by 1,131
Current Status of Gastrointestinal Carcinoids
Modlin, I. M., Kidd, M., Latich, I., Zikusoka, M. N., & Shapiro, M. D. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.03.038 · Cited by 848
Caplin, M. E., Baudin, E., Ferolla, P., Filosso, P., Garcia-Yuste, M., Lim, E., Oberg, K., Pelosi, G., Perren, A., Rossi, R. E., et al. (2015) · Annals of Oncology · doi:10.1093/annonc/mdv041 · Cited by 714
Metadata
- Authors
- Waldherr, C., Pless, M., Maecke, H. R., Haldemann, A., & Mueller-Brand, J.
- Venue
- Annals of Oncology
- Publisher
- Elsevier BV
- Published
- 2001-07
- Volume
- 12
- Issue
- 7
- Pages
- 941-945
- ISSN
- 0923-7534 (ISSN-L)
- OpenAlex
- W1935825021
- Cited by
- 396
- References
- 17
- FWCI
- 13.79
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.